These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20972909)

  • 1. [Association of Omi/HtrA2 expression and prognosis in patients with gastric carcinoma].
    Chen HL; Chen CQ; Ma JP; Cai SR; Wang Z; Yang W; He YL
    Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Oct; 13(10):766-9. PubMed ID: 20972909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The prognostic significance of Omi/HtrA2 expression, and correlation between Omi/HtrA2 and hypoxia-inducible factor-1α in primary hepatocellular carcinoma cells].
    Xu ZQ; Chen XP; Niu J; Liu EY; Li CH; Peng C
    Zhonghua Wai Ke Za Zhi; 2012 Jan; 50(1):49-52. PubMed ID: 22490291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression and clinical significance of Omi/Htra2 in hepatocellular carcinoma.
    Xu Z; Chen X; Peng C; Liu E; Li Y; Li C; Niu J
    Hepatogastroenterology; 2013; 60(121):6-13. PubMed ID: 23682386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis of Omi/HtrA2 expression in stomach cancer.
    Lee SH; Lee JW; Kim HS; Kim SY; Park WS; Kim SH; Lee JY; Yoo NJ
    APMIS; 2003 May; 111(5):586-90. PubMed ID: 12887511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HtrA2/Omi-immunoreactive intraneuronal inclusions in the anterior horn of patients with sporadic and Cu/Zn superoxide dismutase (SOD1) mutant amyotrophic lateral sclerosis.
    Kawamoto Y; Ito H; Kobayashi Y; Suzuki Y; Akiguchi I; Fujimura H; Sakoda S; Kusaka H; Hirano A; Takahashi R
    Neuropathol Appl Neurobiol; 2010 Jun; 36(4):331-44. PubMed ID: 20202124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression levels of the mitochondrial IAP antagonists Smac/DIABLO and Omi/HtrA2 in clear-cell renal cell carcinomas and their prognostic value.
    Kempkensteffen C; Hinz S; Christoph F; Krause H; Magheli A; Schrader M; Schostak M; Miller K; Weikert S
    J Cancer Res Clin Oncol; 2008 May; 134(5):543-50. PubMed ID: 17922292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of Omi/HtrA2 on expression of anti-apoptotic protein PED/PEA-15 and apoptosis of prostate cancer cell line PC-3].
    Hu XY; Chen XC; Zhu ZH; Chen CH; Zeng FQ; Lu GC
    Ai Zheng; 2006 Jun; 25(6):677-82. PubMed ID: 16764760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of AIF and HtrA2/Omi in small lymphocytic lymphoma and diffuse large B-cell lymphoma.
    Li S; Wan M; Cao X; Ren Y
    Arch Pathol Lab Med; 2011 Jul; 135(7):903-8. PubMed ID: 21732781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omi/HtrA2 pro-apoptotic marker differs in various hepatocellular carcinoma cell lines owing to ped/pea-15 expression level.
    Xu Z; Chen Y; Xu G; Peng C; Liu E; Li Y; Niu J; Li C
    Oncol Rep; 2015 Feb; 33(2):905-12. PubMed ID: 25484138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteome-wide Identification of HtrA2/Omi Substrates.
    Vande Walle L; Van Damme P; Lamkanfi M; Saelens X; Vandekerckhove J; Gevaert K; Vandenabeele P
    J Proteome Res; 2007 Mar; 6(3):1006-15. PubMed ID: 17266347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of Omi/HtrA2 expression in prostate cancer and benign prostatic hyperplasia.
    Hu XY; Xu YM; Chen XC; Ping H; Chen ZH; Zeng FQ
    APMIS; 2006 Dec; 114(12):893-8. PubMed ID: 17207090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered enzymatic activity and allele frequency of OMI/HTRA2 in Alzheimer's disease.
    Westerlund M; Behbahani H; Gellhaar S; Forsell C; Belin AC; Anvret A; Zettergren A; Nissbrandt H; Lind C; Sydow O; Graff C; Olson L; Ankarcrona M; Galter D
    FASEB J; 2011 Apr; 25(4):1345-52. PubMed ID: 21163861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic mice with neuron-specific overexpression of HtrA2/Omi suggest a neuroprotective role for HtrA2/Omi.
    Liu MJ; Liu ML; Shen YF; Kim JM; Lee BH; Lee YS; Hong ST
    Biochem Biophys Res Commun; 2007 Oct; 362(2):295-300. PubMed ID: 17707776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omi / HtrA2 is relevant to the selective vulnerability of striatal neurons in Huntington's disease.
    Inagaki R; Tagawa K; Qi ML; Enokido Y; Ito H; Tamura T; Shimizu S; Oyanagi K; Arai N; Kanazawa I; Wanker EE; Okazawa H
    Eur J Neurosci; 2008 Jul; 28(1):30-40. PubMed ID: 18662332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of HtrA2/Omi immunoreactivity in brains affected by Alzheimer's disease.
    Kawamoto Y; Ito H; Kobayashi Y; Suzuki Y; Takahashi R
    Neuroreport; 2010 Dec; 21(17):1121-5. PubMed ID: 20938363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The serine protease Omi/HtrA2 is involved in XIAP cleavage and in neuronal cell death following focal cerebral ischemia/reperfusion.
    Althaus J; Siegelin MD; Dehghani F; Cilenti L; Zervos AS; Rami A
    Neurochem Int; 2007 Jan; 50(1):172-80. PubMed ID: 16978742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways.
    Suzuki Y; Takahashi-Niki K; Akagi T; Hashikawa T; Takahashi R
    Cell Death Differ; 2004 Feb; 11(2):208-16. PubMed ID: 14605674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of Omi/HtrA2 UP-regulated in the spermatozoa of chronic bacterial prostatitis patients].
    Hu XY; Xu YM; Qiao Y; Liu ZS; Song LJ; Li C
    Zhonghua Nan Ke Xue; 2008 Jan; 14(1):47-50. PubMed ID: 18297812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Omi/HtrA2 with γ-secretase in mitochondria.
    Behbahani H; Pavlov PF; Wiehager B; Nishimura T; Winblad B; Ankarcrona M
    Neurochem Int; 2010 Nov; 57(6):668-75. PubMed ID: 20705111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced semen quality in chronic prostatitis patients that induce the release of apoptotic protein Omi/HtrA2 from spermatozoa.
    Hu XY; Xu YM; Qiao Y; Wu DL; Sa YL; Fu Q; Yu JJ; Zhang XR; Zhang J; Gu BJ; Chen R; Xie H
    Prostate Cancer Prostatic Dis; 2007; 10(1):104-8. PubMed ID: 17043678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.